Trial Details
RECRUITINGBasic Information
| Clinical ID | c129 |
|---|---|
| Identifier | NCT07132333 |
| Trial Title | Molecular Inflammation Board at the Center for Personalized Medicine |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Psoriasis (PsO)|Psoriasis Arthritis|Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)|Spondylarthropathies |
| Interventions | BIOLOGICAL: Biologic Agent |
Participant Information
| Sponsor | University Hospital Tuebingen |
|---|---|
| City | Tübingen |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2022-11-16 |
|---|---|
| Primary Completion Date | 2032-11 |
| Completion Date | 2032-11 |